News - Vaccines, Asia-Pacific

Filter

Current filters:

VaccinesAsia-Pacific

Popular Filters

1 to 25 of 32 results

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

10-03-2014

Japanese drug major Daiichi Sankyo has updated on the H5N1 influenza vaccine project, revealing that…

Asia-PacificDaiichi SankyoJapanPharmaceuticalProductionVaccines

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

15-01-2014

Japanese drug major Astellas Pharma and partner UMN Pharma have announced promising summary results for…

Asia-PacificASP7374Astellas PharmaGastro-intestinalsIrribowMarkets & MarketingPharmaceuticalResearchUMN PharmaVaccines

Takeda to sell BIKEN varicella vaccine in Japan

Takeda to sell BIKEN varicella vaccine in Japan

15-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it has reached agreement with the Research Foundation…

Asia-PacificMarkets & MarketingPharmaceuticalTakeda PharmaceuticalsVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

China bans BioKangtai hepatitis B vaccine

26-12-2013

Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine…

Anti-viralsAsia-PacificBioKangtaiChinaHealthcarePharmaceuticalRegulationVaccines

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

Novartis MenB vaccine approved in Australia

15-08-2013

Swiss drug major Novartis (NOVN: VX) revealed this morning (August 15) that the Australian Therapeutic…

Asia-PacificBexseroNovartisPharmaceuticalRegulationVaccines

India's Zydus and IDRI to develop new vaccine for deadly parasitic disease

25-07-2013

India's fourth largest health care group Zydus and non-profit global health organization Infectious Disease…

Asia-PacificPharmaceuticalResearchVaccinesZydus Cadila

Lupin to market MSD vaccine in India

19-07-2013

US pharma giant Merck & Co (NYSE: MRK), known as MSD outside of North America, has entered into an India…

Asia-PacificGenericsLicensingPharmaceuticalVaccines

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA

21-06-2013

The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

India-developed rotavirus vaccine demonstrates strong efficacy

14-05-2013

In a public-private partnership, the Indian government's Department of Biotechnology (DBT) and Bharat…

Asia-PacificBharat BiotechPharmaceuticalResearchROTAVACVaccines

Sinovac rockets on strong data for Enterovirus 71 vaccine

15-03-2013

Chinese vaccines maker Sinovac Biotech Ltd. (Nasdaq: SVA) saw its shares leap 53% to $4.88 in morning…

Asia-PacificEnterovirus 71PharmaceuticalRegulationResearchSinovacVaccines

Sanofi eyes big plans for China

11-02-2013

French pharmaceutical giant Sanofi (Euronext: SAN) plans to complete building a large plant for the production…

Asia-PacificPharmaceuticalProductionSanofiSanofi PasteurVaccines

GlaxoSmithKline and Biological E set up JV to develop combination vaccine

29-01-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and Indian vaccines company Biological E have entered into…

Asia-PacificBiological E LtdGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResearchVaccines

China gains WHO designation for biological products center

20-01-2013

China's Institute for Biological Product Control (IBPC) of the National Institutes for Food and Drug…

Asia-PacificBiotechnologyRegulationVaccines

Japan's seasonal flu vaccines market analysis

16-01-2013

The Japanese influenza vaccine market is valued at around $702 million in 2012, according to a new report…

Anti-viralsAsia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalSanofiVaccines

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

16-12-2012

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585)…

Asia-PacificBiotechnologyCatalent Pharma SolutionsGenericsProductionResearchUMN PharmaVaccines

Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis

11-12-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) has launched its Imojev vaccine against…

Asia-PacificImojevMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

GSK's Synflorix to be used for GAVI pneumococcal vaccines program in Pakistan

10-10-2012

World's largest pneumococcal mass vaccination program is expected to protect up to 4.8 million children…

Asia-PacificGlaxoSmithKlineHealthcareMarkets & MarketingPharmaceuticalSynflorixVaccines

Biological launches Japanese Encephalitis vaccine JEEV in India

13-09-2012

Austria's Intercell AG (VSE: ICLL) that its partner, the Indian vaccines and pharma company Biological…

Asia-PacificBiological E LtdBiotechnologyIntercellJEEVMarkets & MarketingPharmaceuticalVaccines

Australia extends HPV vaccine to schoolboys

12-07-2012

In what is claimed "a world first" by the Department of Health and Ageing, Australian schoolboys will…

Asia-PacificGardasilHealthcareMerck & CoOncologyPharmaceuticalVaccines

New vaccine uptake drives market growth in India

10-07-2012

In India, the government-sponsored Universal Immunization Program procures vaccines at very low prices,…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

1 to 25 of 32 results

Back to top